Vatican Health Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vatican Health Times.

Press releases published on October 30, 2026

7 hours ago

Tangram gibt bekannt, dass der erste Teilnehmer im Rahmen der Phase-I-Studie mit TGM-148, einem neuartigen RNAi-Prüfpräparat zur Behandlung von Blutungsstörungen, die erste Dosis erhalten hat

Indeterminate GlobeNewswire

7 hours ago

Tangram annonce l’administration du TGM-148 au premier participant de l’essai de phase 1 évaluant le TGM-148, un nouveau médicament expérimental à ARNi contre les troubles hémorragiques

Indeterminate GlobeNewswire

8 hours ago

Evaxion receives International Prix Galien Award for AI-Immunology™ as best digital health solution

Indeterminate GlobeNewswire

9 hours ago

Fangzhou Honored with Digital Intelligence Leadership Award at Tencent Summit, Expands Healthcare AI Partnership with Tencent Health

Indeterminate GlobeNewswire

9 hours ago

Nxera Pharma Operational Highlights and Consolidated Results for the Third Quarter 2026

Indeterminate GlobeNewswire

9 hours ago

Nicox Reports First Half 2026 Financial Results

Indeterminate GlobeNewswire

9 hours ago

Nicox publie les résultats financiers du premier semestre 2026

Indeterminate GlobeNewswire

9 hours ago

Press Release: Q3 2026: double-digit growth in sales and business EPS FY 2026: guidance upgraded

Indeterminate GlobeNewswire

9 hours ago

Communiqué de presse : T3 2026 : croissance à deux chiffres du chiffre d’affaires et du BNPA ; révision à la hausse des perspectives 2026

Indeterminate GlobeNewswire

10 hours ago

Leads Biolabs Doses First Patient with Systemic Lupus Erythematosus in Phase I Part B Trial of LBL-047, a First-in-Class BDCA2/TACI Bifunctional Fusion Protein

Indeterminate GlobeNewswire

12 hours ago

2026 InLight Foundation Stanford Frontier Dialogue: From Nobel Optogenetics to Mind-Light Contemplation, Cross-Disciplinary Experts Explore New Frontiers in Consciousness Regulation

Indeterminate GlobeNewswire

13 hours ago

Aspen Neuroscience Announces Pricing of Initial Public Offering

Indeterminate GlobeNewswire

14 hours ago

InnoCare Announces First Subject Dosed in Clinical Trial of TL1A/IL-23p19 Bispecific Antibody ICP-B161 in China

Indeterminate GlobeNewswire